Congressional panel to investigate the Tylenol recall

May 7th, 2010 - 8:44 pm ICT by Aishwarya Bhatt  

fro Washington, May 7 (THAINDIAN NEWS) The US congress has launched an investigation into Johnson and Johnson’s recent recall of Tylenol products. The Committee on Oversight and Government Reform of the US House of Representatives started the investigation after Johnson and Johnson’s MCNeil Consumer Healthcare Unit recalled about 40 widely used pediatric medications from the market, because of bad manufacturing practices that caused contamination and higher concentration of active ingredients than the stated dose contained.

The investigation which is expected to hold its hearing in the coming weeks will question the adequacy of the Food and Drug Administration’s inspection procedures. They are also expected to verify if indeed MCNeil Consumer Healthcare failed to investigate consumer complaints, as stated by the FDA’s initial report.

The FDA issued a very damaging and worrying report on Tuesday of the manufacturing procedures of MCNeil Consumer Healthcare. The report said the company has failed to implement Good Manufacturing Practices (GMP) and this has caused contamination and led to excess quantities of actives in the affected products. The company has since temporary stopped production.

It ought to be mentioned that a report of the Food and Drug administration said that all the Tylenol products that were recalled, were made of ingredients that were contaminated with bacteria. The FDA officials also added that none of the finished products however tested positive for the bacterial contamination, but they did add that the testing was not conclusive and definite. “We think the risk to consumers at this point is remote,” said Deborah Autor, director of FDA’s drug compliance office.

Related Stories

Tags: , , , , , , , , , , , , , , , , , , ,

Posted in Health |

Subscribe